{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:06:51Z","timestamp":1784905611812,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272656"],"award-info":[{"award-number":["81272656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572428"],"award-info":[{"award-number":["81572428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81330014"],"award-info":[{"award-number":["81330014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10620-017-4453-x","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T03:25:28Z","timestamp":1486351528000},"page":"851-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn\u2019s Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"62","author":[{"given":"Yantian","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianlian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"4453_CR1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.gastro.2003.08.024","volume":"125","author":"American Gastroenterological Association medical position statement","year":"2003","unstructured":"American Gastroenterological Association medical position statement. perianal Crohn\u2019s disease. Gastroenterology. 2003;125:1503\u20131507.","journal-title":"Gastroenterology"},{"key":"4453_CR2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.dld.2007.07.152","volume":"39","author":"S Ardizzone","year":"2007","unstructured":"Ardizzone S, Porro GB. Perianal Crohn\u2019s disease: overview. Dig Liver Dis. 2007;39:957\u2013958.","journal-title":"Dig Liver Dis"},{"key":"4453_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-immunol-032414-112151","volume":"34","author":"JM Peloquin","year":"2016","unstructured":"Peloquin JM, Goel G, Villablanca EJ, Xavier RJ. Mechanisms of pediatric inflammatory bowel disease. Annu Rev Immunol. 2016;34:31\u201364.","journal-title":"Annu Rev Immunol"},{"key":"4453_CR4","first-page":"44","volume":"91","author":"P Bansal","year":"1996","unstructured":"Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol. 1996;91:44\u201348.","journal-title":"Am J Gastroenterol"},{"key":"4453_CR5","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","volume":"100","author":"T Jess","year":"2005","unstructured":"Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn\u2019s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724\u20132729.","journal-title":"Am J Gastroenterol"},{"key":"4453_CR6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","volume":"23","author":"C Canavan","year":"2006","unstructured":"Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2006;23:1097\u20131104.","journal-title":"Aliment Pharmacol Ther"},{"key":"4453_CR7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10350-006-0848-z","volume":"50","author":"AC Roon von","year":"2007","unstructured":"von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn\u2019s disease. Dis Colon Rectum. 2007;50:839\u2013855.","journal-title":"Dis Colon Rectum"},{"key":"4453_CR8","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.3748\/wjg.v19.i48.9359","volume":"19","author":"A Algaba","year":"2013","unstructured":"Algaba A, Guerra I, Castano A, et al. Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease. World J Gastroenterol. 2013;19:9359\u20139365.","journal-title":"World J Gastroenterol"},{"key":"4453_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000228577","volume":"27","author":"L Beaugerie","year":"2009","unstructured":"Beaugerie L, Sokol H, Seksik P. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye. Dig Dis (Basel, Switzerland). 2009;27:375\u2013381.","journal-title":"Dig Dis (Basel, Switzerland)"},{"key":"4453_CR10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.crohns.2011.04.013","volume":"5","author":"KH Katsanos","year":"2011","unstructured":"Katsanos KH, Tatsioni A, Pedersen N, et al. Cancer in inflammatory bowel disease 15\u00a0years after diagnosis in a population-based European collaborative follow-up study. J Crohn\u2019s Colitis. 2011;5:430\u2013442.","journal-title":"J Crohn\u2019s Colitis"},{"key":"4453_CR11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","volume":"105","author":"N Pedersen","year":"2010","unstructured":"Pedersen N, Duricova D, Elkjaer M, Gamborg M, Munkholm P, Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480\u20131487.","journal-title":"Am J Gastroenterol"},{"key":"4453_CR12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u2013444.","journal-title":"Nature"},{"key":"4453_CR13","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Blanc Le","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (London, England). 2008;371:1579\u20131586.","journal-title":"Lancet (London, England)"},{"key":"4453_CR14","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815\u20131822.","journal-title":"Blood"},{"key":"4453_CR15","doi-asserted-by":"crossref","unstructured":"Alvaro-Gracia JM, Jover JA, Garcia-Vicuna R, et al. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial. Ann Rheum Dis. 2016.","DOI":"10.1136\/annrheumdis-2015-208918"},{"key":"4453_CR16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/gutjnl-2015-309836","volume":"65","author":"A Jauregui-Amezaga","year":"2016","unstructured":"Jauregui-Amezaga A, Rovira M, Marin P, et al. Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn\u2019s disease. Gut. 2016;65:1456\u20131462.","journal-title":"Gut"},{"key":"4453_CR17","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1002\/stem.2197","volume":"33","author":"R Lin","year":"2015","unstructured":"Lin R, Ding Z, Ma H, et al. In vitro conditioned bone marrow-derived mesenchymal stem cells promote de novo functional enteric nerve regeneration, but not through direct-transdifferentiation. Stem Cells (Dayton, Ohio). 2015;33:3545\u20133557.","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"4453_CR18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1089\/scd.2013.0166","volume":"22","author":"R Lin","year":"2013","unstructured":"Lin R, Ma H, Ding Z, et al. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer. Stem Cells Dev. 2013;22:2836\u20132848.","journal-title":"Stem Cells Dev"},{"key":"4453_CR19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","volume":"59","author":"M Duijvestein","year":"2010","unstructured":"Duijvestein M, Vos AC, Roelofs H, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn\u2019s disease: results of a phase I study. Gut. 2010;59:1662\u20131669.","journal-title":"Gut"},{"key":"4453_CR20","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","volume":"48","author":"D Garcia-Olmo","year":"2005","unstructured":"Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48:1416\u20131423.","journal-title":"Dis Colon Rectum"},{"key":"4453_CR21","doi-asserted-by":"crossref","first-page":"918.e916","DOI":"10.1053\/j.gastro.2015.06.014","volume":"149","author":"I Molendijk","year":"2015","unstructured":"Molendijk I, Bonsing BA, Roelofs H, et al. Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2015;149:918.e916\u2013927.e916.","journal-title":"Gastroenterology"},{"key":"4453_CR22","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1517\/14712598.8.9.1417","volume":"8","author":"D Garcia-Olmo","year":"2008","unstructured":"Garcia-Olmo D, Garcia-Arranz M, Herreros D. Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn\u2019s disease. Exp Opin Biol Ther. 2008;8:1417\u20131423.","journal-title":"Exp Opin Biol Ther"},{"key":"4453_CR23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.5966\/sctm.2014-0255","volume":"4","author":"R Sanz-Baro","year":"2015","unstructured":"Sanz-Baro R, Garcia-Arranz M, Guadalajara H, de la Quintana P, Herreros MD, Garcia-Olmo D. First-in-human case study: pregnancy in women with Crohn\u2019s perianal fistula treated with adipose-derived stem cells: a safety study. Stem Cells Transl Med. 2015;4:598\u2013602.","journal-title":"Stem Cells Transl Med"},{"key":"4453_CR24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.mayocp.2015.03.023","volume":"90","author":"R Ciccocioppo","year":"2015","unstructured":"Ciccocioppo R, Gallia A, Sgarella A, Kruzliak P, Gobbi PG, Corazza GR. Long-term follow-up of CD fistulas after local injections of bone marrow-derived mesenchymal stem cells. Mayo Clin Proc. 2015;90:747\u2013755.","journal-title":"Mayo Clin Proc"},{"key":"4453_CR25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","volume":"28","author":"F Portilla de la","year":"2013","unstructured":"de la Portilla F, Alba F, Garcia-Olmo D, Herrerias JM, Gonzalez FX, Galindo A. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn\u2019s disease: results from a multicenter phase I\/IIa clinical trial. Int J Colorectal Dis. 2013;28:313\u2013323.","journal-title":"Int J Colorectal Dis"},{"key":"4453_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2015.2653","volume":"73","author":"MK Georgakis","year":"2016","unstructured":"Georgakis MK, Thomopoulos TP, Diamantaras AA, et al. Association of age at menopause and duration of reproductive period with depression after menopause: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73:139\u2013149.","journal-title":"JAMA Psychiatry"},{"key":"4453_CR27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"RL Ownby","year":"2006","unstructured":"Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63:530\u2013538.","journal-title":"Arch Gen Psychiatry"},{"key":"4453_CR28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Research ed). 2003;327:557\u2013560.","journal-title":"BMJ (Clinical Research ed)"},{"key":"4453_CR29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","volume":"12","author":"GM Forbes","year":"2014","unstructured":"Forbes GM, Sturm MJ, Leong RW, et al. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn\u2019s disease refractory to biologic therapy. Clin Gastroenterol Hepatol. 2014;12:64\u201371.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4453_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10517-013-2297-8","volume":"156","author":"OV Knyazev","year":"2013","unstructured":"Knyazev OV, Parfenov AI, Shcherbakov PL, Ruchkina IN, Konoplyannikov AG. Cell therapy of refractory Crohn\u2019s disease. Bull Exp Biol Med. 2013;156:139\u2013145.","journal-title":"Bull Exp Biol Med"},{"key":"4453_CR31","doi-asserted-by":"crossref","unstructured":"Garcia-Arranz M, Dolores Herreros M, Gonzalez-Gomez C, et al. Treatment of Crohn\u2019s-related rectovaginal fistula with allogeneic expanded-adipose derived stem cells: a phase I\u2013IIa clinical trial. Stem Cells Trans Med. 2016.","DOI":"10.5966\/sctm.2015-0356"},{"key":"4453_CR32","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3748\/wjg.v21.i11.3330","volume":"21","author":"D Garcia-Olmo","year":"2015","unstructured":"Garcia-Olmo D, Guadalajara H, Rubio-Perez I, Herreros MD, de-la-Quintana P, Garcia-Arranz M. Recurrent anal fistulae: limited surgery supported by stem cells. World J Gastroenterol. 2015;21:3330\u20133336.","journal-title":"World J Gastroenterol"},{"key":"4453_CR33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00384-011-1350-1","volume":"27","author":"H Guadalajara","year":"2012","unstructured":"Guadalajara H, Herreros D, De-La-Quintana P, Trebol J, Garcia-Arranz M, Garcia-Olmo D. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis. 2012;27:595\u2013600.","journal-title":"Int J Colorectal Dis"},{"key":"4453_CR34","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00595-015-1246-8","volume":"46","author":"T Mizushima","year":"2016","unstructured":"Mizushima T, Takahashi H, Takeyama H, et al. A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula. Surg Today. 2016;46:835\u2013842.","journal-title":"Surg Today"},{"key":"4453_CR35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","volume":"60","author":"R Ciccocioppo","year":"2011","unstructured":"Ciccocioppo R, Bernardo ME, Sgarella A, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn\u2019s disease. Gut. 2011;60:788\u2013798.","journal-title":"Gut"},{"key":"4453_CR36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5966\/sctm.2014-0199","volume":"4","author":"YB Cho","year":"2015","unstructured":"Cho YB, Park KJ, Yoon SN, Song KH, et al. Long-term results of adipose-derived stem cell therapy for the treatment of Crohn\u2019s fistula. Stem Cells Transl Med. 2015;4:532\u2013537.","journal-title":"Stem Cells Transl Med"},{"key":"4453_CR37","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/stem.1357","volume":"31","author":"WY Lee","year":"2013","unstructured":"Lee WY, Park KJ, Cho YB, Yoon SN, Song KH, et al. Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn\u2019s fistula. Stem Cells (Dayton, Ohio). 2013;31:2575\u20132581.","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"4453_CR38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3727\/096368912X656045","volume":"22","author":"YB Cho","year":"2013","unstructured":"Cho YB, Lee WY, Park KJ, Kim M, Yoo HW, Yu CS. Autologous adipose tissue-derived stem cells for the treatment of Crohn\u2019s fistula: a phase I clinical study. Cell Transplant. 2013;22:279\u2013285.","journal-title":"Cell Transplant"},{"key":"4453_CR39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","volume":"52","author":"D Garcia-Olmo","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009;52:79\u201386.","journal-title":"Dis Colon Rectum"},{"key":"4453_CR40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/codi.13223","volume":"18","author":"KJ Park","year":"2016","unstructured":"Park KJ, Ryoo SB, Kim JS, et al. Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn\u2019s disease: a pilot clinical trial. Colorectal Dis. 2016;18:468\u2013476.","journal-title":"Colorectal Dis"},{"key":"4453_CR41","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Panes","year":"2016","unstructured":"Panes J, Garcia-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet (London, England). 2016;388:1281\u20131290.","journal-title":"Lancet (London, England)"},{"key":"4453_CR42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00384-008-0559-0","volume":"24","author":"D Garcia-Olmo","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual M, et al. Treatment of enterocutaneous fistula in Crohn\u2019s disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. Int J Colorectal Dis. 2009;24:27\u201330.","journal-title":"Int J Colorectal Dis"},{"key":"4453_CR43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn\u2019s disease. N Engl J Med. 2004;350:876\u2013885.","journal-title":"N Engl J Med"},{"key":"4453_CR44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00054725-200203000-00007","volume":"8","author":"C Levy","year":"2002","unstructured":"Levy C, Tremaine WJ. Management of internal fistulas in Crohn\u2019s disease. Inflamm Bowel Dis. 2002;8:106\u2013111.","journal-title":"Inflamm Bowel Dis"},{"key":"4453_CR45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","volume":"123","author":"DC Pearson","year":"1995","unstructured":"Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in CD. A meta-analysis. Ann Intern Med. 1995;123:132\u2013142.","journal-title":"Ann Intern Med"},{"key":"4453_CR46","first-page":"83","volume":"10","author":"J Hermann","year":"2015","unstructured":"Hermann J, Eder P, Banasiewicz T, Matysiak K, Lykowska-Szuber L. Current management of anal fistulas in Crohn\u2019s disease. Prz Gastroenterol. 2015;10:83\u201388.","journal-title":"Prz Gastroenterol"},{"key":"4453_CR47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0036-1580631","volume":"29","author":"RT Akiba","year":"2016","unstructured":"Akiba RT, Rodrigues FG, da Silva G. Management of complex perineal fistula disease. Clin Colon Rectal Surg. 2016;29:92\u2013100.","journal-title":"Clin Colon Rectal Surg"},{"key":"4453_CR48","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","volume":"63","author":"KB Gecse","year":"2014","unstructured":"Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn\u2019s disease. Gut. 2014;63:1381\u20131392.","journal-title":"Gut"},{"key":"4453_CR49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1463-1318.2008.01713.x","volume":"11","author":"RD Ritchie","year":"2009","unstructured":"Ritchie RD, Sackier JM, Hodde JP. Incontinence rates after cutting seton treatment for anal fistula. Colorectal Dis. 2009;11:564\u2013571.","journal-title":"Colorectal Dis"},{"key":"4453_CR50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/bjs.6608","volume":"96","author":"PJ Koperen van","year":"2009","unstructured":"van Koperen PJ, Safiruddin F, Bemelman WA, Slors JF. Outcome of surgical treatment for fistula in ano in Crohn\u2019s disease. Br J Surg. 2009;96:675\u2013679.","journal-title":"Br J Surg"},{"key":"4453_CR51","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0016-5085(03)00392-5","volume":"124","author":"DH Present","year":"2003","unstructured":"Present DH. Crohn\u2019s fistula: current concepts in management. Gastroenterology. 2003;124:1629\u20131635.","journal-title":"Gastroenterology"},{"key":"4453_CR52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/apt.13001","volume":"41","author":"R Khanna","year":"2015","unstructured":"Khanna R, Zou G, D\u2019Haens G, et al. A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn\u2019s disease activity. Aliment Pharmacol Ther. 2015;41:77\u201386.","journal-title":"Aliment Pharmacol Ther"},{"key":"4453_CR53","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0016-5085(79)90384-6","volume":"77","author":"WR Best","year":"1979","unstructured":"Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn\u2019s Disease Activity Index (CDAI). Gastroenterology. 1979;77:843\u2013846.","journal-title":"Gastroenterology"},{"key":"4453_CR54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","volume":"63","author":"L Peyrin-Biroulet","year":"2014","unstructured":"Peyrin-Biroulet L, Reinisch W, Colombel JF, et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn\u2019s disease in the SONIC trial. Gut. 2014;63:88\u201395.","journal-title":"Gut"},{"key":"4453_CR55","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.athoracsur.2008.11.057","volume":"87","author":"H Hamamoto","year":"2009","unstructured":"Hamamoto H, Gorman JH, Ryan LP, et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg. 2009;87:794\u2013801.","journal-title":"Ann Thorac Surg"},{"key":"4453_CR56","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308:2369\u20132379.","journal-title":"JAMA"},{"key":"4453_CR57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOT.0000000000000036","volume":"19","author":"MJ Hoogduijn","year":"2008","unstructured":"Hoogduijn MJ, Betjes MG, Baan CC. Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics? Curr Opin Organ Transpl. 2008;19:41\u201346.","journal-title":"Curr Opin Organ Transpl"},{"key":"4453_CR58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10620-016-4166-6","volume":"62","author":"M Xie","year":"2017","unstructured":"Xie M, Qin H, Luo Q, et al. Comparison of adipose-derived and bone marrow mesenchymal stromal cells in a murine model of Crohn\u2019s disease. Dig Dis Sci. 2017;62:115\u2013123.","journal-title":"Dig Dis Sci"},{"key":"4453_CR59","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/stem.1432","volume":"31","author":"SM Melief","year":"2013","unstructured":"Melief SM, Schrama E, Brugman MH, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 2013;31:1980\u20131991.","journal-title":"Stem Cells"},{"key":"4453_CR60","doi-asserted-by":"crossref","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7:e47559.","journal-title":"PLoS One"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4453-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4453-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4453-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T05:02:12Z","timestamp":1568782932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4453-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["4453"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4453-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]}}}